Next Level Blood Purification:
Find out more about the new ADVOS BK300.

Tina Thanner

ADVITOS takes third place at the EIT Health Summit 2019 in Paris

02.12.2019 Munich – After a final pitch contest ADVITOS takes the third place among the MedTech companies. 21 finalists in the categories MedTech, BioTech and Digital Health had been training and competing since spring 2019 to reach the finals of the European Health Catapult (EHC). The biggest pitch contest organised by EIT Health, EHC is […]

ADVITOS takes third place at the EIT Health Summit 2019 in Paris Read More »

ADVITOS is prize winner and the only MedTech company in this year’s Deloitte Technology Fast 50 Award – Germany’s fastest-growing technology companies.

11.11.2019 Munich – With a growth rate of 680 percent, the Munich-based company ADVITOS manages to reach 27th place in the Deloitte Technology Fast 50 2019. With the Technology Fast 50 Award Deloitte annually honors the fastest-growing technology companies in the sectors of Hardware, Software, Communications, Media & Entertainment, Healthcare & Life Sciences, Environmental Technology

ADVITOS is prize winner and the only MedTech company in this year’s Deloitte Technology Fast 50 Award – Germany’s fastest-growing technology companies. Read More »

ADVITOS has been named one of Hello Tomorrow’s Deep Tech Pioneers

06.11.2019 Munich – Munich-based ADVITOS has been selected among 5,000 applications from 128 different countries as one of Hello Tomorrow’s Deep Tech Pioneers The Hello Tomorrow Global Challenge is a renowned global startup competition designed specifically to address the needs of deep tech entrepreneurs across several industries. The Challenge gives scientists and deep tech entrepreneurs

ADVITOS has been named one of Hello Tomorrow’s Deep Tech Pioneers Read More »

ADVITOS receives EIC Accelerator (SME Instrument Phase 2) funding from the European Union.

16.10.2019 Munich – Munich-based ADVITOS receives €2.3m EIC Accelerator grant from the European Union and Seal of Excellence for first class innovations. “We are very excited to receive such a prestigious and international recognition by the European Union. It is our honor to hold the Seal of Excellence for first-class innovations worth of investment in

ADVITOS receives EIC Accelerator (SME Instrument Phase 2) funding from the European Union. Read More »

ADVITOS is MedTech finalist at the European Health Catapult Competition

02.10.2019 Munich – Munich-based ADVITOS is selected as a European finalist in the EIT European Health Catapult program The European Health Catapult (EHC) is a training and competition program that boosts the development of top-notch European health start-ups through exposure to leading experts and international investors. The program is organized by EIT Health with the

ADVITOS is MedTech finalist at the European Health Catapult Competition Read More »

Hepa Wash Initiates Collaboration with German Accelerator Life Sciences to Prepare U.S. Expansion

07.12.2017 Company’s ADVOS Technology Represents First System Worldwide for Advanced Multi-Organ Support Munich, Germany, December 7, 2017 – Hepa Wash, a Munich-based manufacturer of the worldwide first method for advanced multi-organ support, announced today its collaboration with the German Accelerator Life Sciences (GALS) program, an initiative founded by the German Federal Ministry for Economic Affairs

Hepa Wash Initiates Collaboration with German Accelerator Life Sciences to Prepare U.S. Expansion Read More »

Scroll to Top